R-KY·U.S. House·District 2

Brett Guthrie

THE TAKETrailAI · auto-generated

Representative Brett Guthrie's fundraising is heavily weighted toward PAC and committee contributions, which comprise 71 percent of his $10.7 million total, with individual donors accounting for the remaining 29 percent. His industry-tied PAC money concentrates in health services, pharmaceuticals and biotech, and lawyers and lobbyists, reflecting a donor base aligned with regulated sectors and professional services. Individual donors employed in his top-contributing sectors—lawyers, health services, and telecommunications—track closely with his overall contribution profile.

Raised · all cycles$10.7M▲ 71% in ’24 vs ’22#32 in party · by cycle ↴

Top sector share23%Health Services

Donor-sector votes21on bills touching top donor sectors

FOLLOW THE MONEY

Left: who funds Guthrie (ribbon width = dollars) · right: their votes on bills classified as favoring vs limiting those sectors

“Favors / limits” is an AI classification of each bill's likely effect on the sector — a factual reading of the bill, not a claim about motive. Correlation, not causation. The named bills are in DOES THE MONEY MATCH THE VOTES? below.

DOES THE MONEY MATCH THE VOTES?

How Guthrie voted on bills touching their biggest donor sectors · 6 of 21 shown, ranked by sector money

✕NAY

Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.

HR6833-117 · Pharmaceuticals & Biotech

$1.2M in

✓YEA

Medical Marijuana and Cannabidiol Research Expansion Act This bill establishes a new, separate registration process to facilitate research on marijuan

HR8454-117 · Pharmaceuticals & Biotech

$1.2M in

✓YEA

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic

HR3537-117 · Pharmaceuticals & Biotech

$1.2M in

✓YEA

Ensuring Compliance Against Drug Diversion Act of 2021 This bill provides statutory authority for certain regulations governing the modification, tran

HR1899-117 · Pharmaceuticals & Biotech

$1.2M in

✓YEA

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021 This bill authorizes the Drug Enforcement Administration (DEA) to

HR1002-117 · Pharmaceuticals & Biotech

$1.2M in

✓YEA

Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among heal

S164-117 · Pharmaceuticals & Biotech

$1.2M in

Each dollar figure is Guthrie's total from that donor sector — shown on each related vote, not a per-vote amount. Correlation between funding and votes, not causation; many factors shape any single vote.

TOP SOURCES

ATT

employees

$118K

GOOGLE

employees

$70K

MEHLMAN CONSULTING

employees

$62K

COMCAST

employees

$54K

BGR GROUP

employees

$48K

View all donors →

ALIGNMENT SIGNALS

Committee–Donor Overlap95%

Brett Guthrie (R) chairs the Energy and Commerce committee overseeing Health Services — their largest tracked donor sector (22%)

Brett Guthrie (R-KY) chairs the House Committee on Energy and Commerce, which has jurisdiction over the Health Services sector. Health Services comprises 22.4% of his donor base ($2.39M), ranking him #9 among Republicans in donor concentration from this sector.

Sector-Aligned Voting94%

Brett Guthrie (R) voted YEA on 11 of 11 bills classified as favoring their donor sectors — #27 rate in the House

Rep. Guthrie voted yes on 100% of bills classified as favoring Pharmaceuticals & Biotech, Telecommunications, and Technology—his top donor sectors—ranking #27 highest among House members on this metric. He voted yes on HR3537-117, classified as favoring Pharmaceuticals & Biotech, which accelerated access to critical therapies for ALS, and also voted yes on 5 of 6 bills classified as limiting those same sectors.

LEGISLATION

2 sponsored

●

SUPPORT for Patients and Communities Reauthorization Act of 2025

HR2483-119 · Signed

●

BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024

HR7218-118 · Signed

COMMITTEES

Energy and Commerce · Chair

SIMILAR DONOR NETWORKS

Members funded by the same industries — overlapping donor networks may reflect shared policy interests.